| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1cee02915dd45eee989cfde8d6338757
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5e2b3aa5ca15921010469c99446069bb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2d52cfb9f558b8f42d495d291a845fc9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_76c3725c1916443daa80e7b18b12cdf7 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2500-90
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2533-92
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2500-25
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-15
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2500-14 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0629
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0605
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-063 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-074
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-073
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-071
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12M3-00 |
| filingDate |
2006-06-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5b9f2dccb894eb1fdf823c57d2dd8984
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3bef7648a202472aa8a811b902b09214
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7b9dddca40ad99d61a517bc8a12ea536 |
| publicationDate |
2007-01-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2007002900-A1 |
| titleOfInvention |
Ex vivo expansion of primary animal cells |
| abstract |
An ex vivo method of expanding animal cells whose differentiation state is controllable by modulating TGF-β signaling includes the steps of: (a) providing an animal subject having cells with a first phenotype; (b) isolating the cells from the animal subject; (c) placing the cells in an ex vivo culture system including a culture vessel having at least one surface and a medium in contact with the at least one surface, the medium being essentially free of intact amniotic membrane and feeder cells; and (d) culturing the cells in the medium under conditions which downregulate TGF-β signaling in the cells and allow the cells to proliferate while maintaining the first phenotype. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2016161192-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10514163-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107636149-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9790471-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103142447-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9963680-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-2016243750-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2018532389-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11680246-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3892717-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3892718-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10119121-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2018512890-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10100285-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11060715-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2017044454-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2008002329-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3822339-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10711250-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10711251-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10066201-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2008002329-A2 |
| priorityDate |
2005-06-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |